AbbVie Already Dividend King? Why Apogee Deal Could Cement a Dynasty
AbbVie has quietly built a credible dividend track record since its 2013 spin-off from Abbott. The $10.9B Apogee deal...
Understanding when to start thinking about retirement can make a big difference. Explore key factors to help you plan effectively.
24,441 articlesAbbVie has quietly built a credible dividend track record since its 2013 spin-off from Abbott. The $10.9B Apogee deal...
A wave of AI anxiety moved from online whispers to market headlines this week, forcing households to rethink budgets,...
A shifting market backdrop has investors turning to high-yield, dividend-growing names. Three dividend king stocks th...
As the world watches the Strait of Hormuz, Canada’s Pacific energy links rise in importance. Kitimat LNG and the Tran...
In Florida, trump hates voting mail—except, as ballots are cast, the president shows a paradox that highlights the po...
President Donald Trump plans up to four in-person talks with Xi Jinping within eight months as Air Force One heads to...
Wouldn’t your entire 401(K) be better diversified than betting all spend on a single rewards program? As loyalty prog...
A Kuwaiti air base attack injures Americans while Washington wavers on a potential Iran ceasefire extension. The unfo...
Two COOs rose to the top job in 2024-2026 and reveal what truly matters in the COO-to-CEO transition, from alignment ...
SpaceX began trading on Friday with a roughly $2 trillion market value after an IPO that stunned markets. The company...
Two top physical silver ETFs face off as 2026 volatility tests liquidity and cost. This report breaks down which is s...
Citigroup boosts its SanDisk price target to $2,500, arguing a multi-year datacenter expansion and a tighter NAND cyc...